REBECCA ANDRESEN: Open Payments
NPI 1720662992 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$781 in 38 payments from 11 companies in 2025. Trend: 2023 $1,562 · 2024 $1,267 · 2025 $781
Food & beverage: $781
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $347 |
| Novo Nordisk Inc | 5 | $97 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $58 |
| AstraZeneca Pharmaceuticals LP | 4 | $57 |
| PFIZER INC. | 3 | $57 |
| Lilly USA, LLC | 3 | $53 |
| Inspire Medical Systems, Inc. | 1 | $45 |
| SANOFI-AVENTIS U.S. LLC | 1 | $19 |
| Janssen Pharmaceuticals, Inc | 1 | $18 |
| LEO Pharma Inc. | 1 | $15 |
Products named: QULIPTA, VRAYLAR, Wegovy, Kerendia, MOUNJARO, INSPIRE, VYNDAMAX, TZIELD.
Industry payments across NE — which companies pay providers there.
